GSE132486

syn77081073

Created By Aditya Nath aditya.nath

doi: 10.1172/JCI134424
title: JAK2 inhibition in Philadelphia chromosome like acute lymphoblastic leukemia
funder: NIH-NCI
series:
creator: Hurtz Christian Carroll Martin Tasian Sarah
license: CC-BY 4.0
species: Homo sapiens
studyId: syn22117059
subject:
ageGroup:
citation: Hurtz C et al. (2020). Oncogene-independent BCR-like signaling adaptation confers drug resistance in Ph-like ALL. J Clin Invest. 130(7):3637-3653. doi: 10.1172/JCI134424
dataType: gene expression
keywords:
accessType: Open Access
contributor:
description: CRLF2 rearranged Ph-like ALL cells are driven by oncogenic cytokine receptor signaling mediated by CRLF2 and JAK2. MHH-cALL4 cells were treated with ruxolotinib (JAK2 inhibitor) to provide insight into mechanisms of drug resistance.
grantNumber: CA243072
diseaseFocus:
downloadType: Synapse Hosted
alternateName: GSE132486
manifestation:
specimenCount: 6
yearProcessed: 2019
countryOfOrigin:
individualCount: 1
visualizeDataOn:
dataUseModifiers:
conditionsOfAccess: No restriction
measurementTechnique: RNA array
externalRepositoryUri: geo:GSE132486
includedInDataCatalog:

GSE132486 page is loading…